Impact of catheter ablation versus medical therapy on cognitive function in atrial fibrillation: a systematic review.
Impact of catheter ablation versus medical therapy on cognitive function in atrial fibrillation: a systematic review.
复制标题
DOI:
10.1007/s10840-022-01196-y
复制
发表时间:
2022-10
影响因子:
1.8
通讯作者:
Williams, Steven E.
中科院分区:
文献类型:
--
作者:
Bodagh, Neil;Yap, Reuben;Kotadia, Irum;Sim, Iain;Bhalla, Ajay;Somerville, Peter;O'Neill, Mark;Williams, Steven E.
Atrial fibrillation is associated with an increased risk of cognitive impairment. It is unclear whether the restoration of sinus rhythm with catheter ablation may modify this risk. We conducted a systematic review of studies comparing cognitive outcomes following catheter ablation with medical therapy (rate and/or rhythm control) in atrial fibrillation. Searches were performed on the following databases from their inception to 17 October 2021: PubMed, OVID Medline, Embase and Cochrane Library. The inclusion criteria comprised studies comparing catheter ablation against medical therapy (rate and/or rhythm control in conjunction with anticoagulation where appropriate) which included cognitive assessment and/or a diagnosis of dementia as an outcome. A total of 599 records were screened. Ten studies including 15,886 patients treated with catheter ablation and 42,684 patients treated with medical therapy were included. Studies which compared the impact of catheter ablation versus medical therapy on quantitative assessments of cognitive function yielded conflicting results. In studies, examining new onset dementia during follow-up, catheter ablation was associated with a lower risk of subsequent dementia diagnosis compared to medical therapy (hazard ratio: 0.60 (95% confidence interval 0.42–0.88, p < 0.05)). The accumulating evidence linking atrial fibrillation with cognitive impairment warrants the design of atrial fibrillation treatment strategies aimed at minimising cognitive decline. However, the impact of catheter ablation and atrial fibrillation medical therapy on cognitive decline is currently uncertain. Future studies investigating atrial fibrillation treatment strategies should include cognitive outcomes as important clinical endpoints. The online version contains supplementary material available at 10.1007/s10840-022-01196-y.
登录
查看更多内容
影响因子:
39.3
作者:
Kirchhof P;Haeusler KG;Blank B;De Bono J;Callans D;Elvan A;Fetsch T;Van Gelder IC;Gentlesk P;Grimaldi M;Hansen J;Hindricks G;Al-Khalidi HR;Massaro T;Mont L;Nielsen JC;Nölker G;Piccini JP;De Potter T;Scherr D;Schotten U;Themistoclakis S;Todd D;Vijgen J;Di Biase L
通讯作者:
Di Biase L
影响因子:
8.3
作者:
Sigurdsson S;Aspelund T;Kjartansson O;Gudmundsson EF;Jonsdottir MK;Eiriksdottir G;Jonsson PV;van Buchem MA;Gudnason V;Launer LJ
通讯作者:
Launer LJ
DOI:
10.1136/heartjnl-2020-316612
发表时间:
2020-12
期刊:
Heart (British Cardiac Society)
影响因子:
--
作者:
Piccini JP;Todd DM;Massaro T;Lougee A;Haeusler KG;Blank B;de Bono JP;Callans DJ;Elvan A;Fetsch T;Van Gelder I;Gentlesk P;Grimaldi M;Hansen J;Hindricks G;Al-Khalidi H;Mont L;Nielsen JC;Noelker G;De Potter T;Scherr D;Schotten U;Themistoclakis S;Vijgen J;Di Biase L;Kirchhof P
通讯作者:
Kirchhof P
影响因子:
4.6
作者:
Kato N;Muraga K;Hirata Y;Shindo A;Matsuura K;Ii Y;Shiga M;Tabei KI;Satoh M;Fujita S;Fukuma T;Kagawa Y;Fujii E;Umino M;Maeda M;Sakuma H;Ito M;Tomimoto H
通讯作者:
Tomimoto H
影响因子:
5.5
作者:
Schwarz, Niko;Kuniss, Malte;Gerriets, Tibo
通讯作者:
Gerriets, Tibo